Literature DB >> 29899038

Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma.

Andreas M Neophytou1, Sam S Oh2, Marquitta J White2, Angel C Y Mak2, Donglei Hu2, Scott Huntsman2, Celeste Eng2, Denise Serebrisky3, Luisa N Borrell4, Harold J Farber5, Kelley Meade6, Adam Davis6, Pedro C Avila7, Shannon M Thyne8, William Rodríguez-Cintrón9, José R Rodríguez-Santana10, Rajesh Kumar11,12, Emerita Brigino-Buenaventura13, Saunak Sen14, Michael A Lenoir15, L Keoki Williams16,17, Neal L Benowitz2, John R Balmes1,2, Ellen A Eisen1, Esteban G Burchard2.   

Abstract

BACKGROUND: Secondhand smoke (SHS) exposures have been linked to asthma-related outcomes but quantitative dose-responses using biomarkers of exposure have not been widely reported.
OBJECTIVES: Assess dose-response relationships between plasma cotinine-determined SHS exposure and asthma outcomes in minority children, a vulnerable population exposed to higher levels of SHS and under-represented in the literature.
METHODS: We performed analyses in 1172 Latino and African-American children with asthma from the mainland USA and Puerto Rico. We used logistic regression to assess relationships of cotinine levels ≥0.05 ng/mL with asthma exacerbations (defined as asthma-related hospitalisations, emergency room visits or oral steroid prescription) in the previous year and asthma control. The shape of dose-response relationships was assessed using a continuous exposure variable in generalised additive logistic models with penalised splines.
RESULTS: The OR for experiencing asthma exacerbations in the previous year for cotinine levels ≥0.05 ng/mL, compared with <0.05 ng/mL, was 1.40 (95% CI 1.03 to 1.89), while the OR for poor asthma control was 1.53 (95% CI 1.12 to 2.13). Analyses for dose-response relationships indicated increasing odds of asthma outcomes related with increasing exposure, even at cotinine levels associated with light SHS exposures.
CONCLUSIONS: Exposure to SHS was associated with higher odds of asthma exacerbations and having poorly controlled asthma with an increasing dose-response even at low levels of exposure. Our results support the conclusion that there are no safe levels of SHS exposures. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  asthma epidemiology; tobacco and the lung

Mesh:

Substances:

Year:  2018        PMID: 29899038      PMCID: PMC6225993          DOI: 10.1136/thoraxjnl-2017-211383

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  37 in total

1.  Genetic ancestry in lung-function predictions.

Authors:  Rajesh Kumar; Max A Seibold; Melinda C Aldrich; L Keoki Williams; Alex P Reiner; Laura Colangelo; Joshua Galanter; Christopher Gignoux; Donglei Hu; Saunak Sen; Shweta Choudhry; Edward L Peterson; Jose Rodriguez-Santana; William Rodriguez-Cintron; Michael A Nalls; Tennille S Leak; Ellen O'Meara; Bernd Meibohm; Stephen B Kritchevsky; Rongling Li; Tamara B Harris; Deborah A Nickerson; Myriam Fornage; Paul Enright; Elad Ziv; Lewis J Smith; Kiang Liu; Esteban González Burchard
Journal:  N Engl J Med       Date:  2010-07-07       Impact factor: 91.245

2.  Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies.

Authors:  D P Strachan; D G Cook
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

3.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

4.  Moving toward true inclusion of racial/ethnic minorities in federally funded studies. A key step for achieving respiratory health equality in the United States.

Authors:  Esteban G Burchard; Sam S Oh; Marilyn G Foreman; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

Review 5.  Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis.

Authors:  Hannah Burke; Jo Leonardi-Bee; Ahmed Hashim; Hembadoon Pine-Abata; Yilu Chen; Derek G Cook; John R Britton; Tricia M McKeever
Journal:  Pediatrics       Date:  2012-03-19       Impact factor: 7.124

6.  The accumulated evidence on lung cancer and environmental tobacco smoke.

Authors:  A K Hackshaw; M R Law; N J Wald
Journal:  BMJ       Date:  1997-10-18

7.  Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries.

Authors:  Mattias Oberg; Maritta S Jaakkola; Alistair Woodward; Armando Peruga; Annette Prüss-Ustün
Journal:  Lancet       Date:  2011-01-08       Impact factor: 79.321

8.  Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children.

Authors:  F D Gilliland; Y F Li; J M Peters
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

9.  Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos.

Authors:  R Graham Barr; Larissa Avilés-Santa; Sonia M Davis; Tom K Aldrich; Franklyn Gonzalez; Ashley G Henderson; Robert C Kaplan; Lisa LaVange; Kiang Liu; Jose S Loredo; Eliana S Mendes; Ai Ni; Andrew Ries; Matthias Salathe; Lewis J Smith
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

10.  Genetic ancestry influences asthma susceptibility and lung function among Latinos.

Authors:  Maria Pino-Yanes; Neeta Thakur; Christopher R Gignoux; Joshua M Galanter; Lindsey A Roth; Celeste Eng; Katherine K Nishimura; Sam S Oh; Hita Vora; Scott Huntsman; Elizabeth A Nguyen; Donglei Hu; Katherine A Drake; David V Conti; Andres Moreno-Estrada; Karla Sandoval; Cheryl A Winkler; Luisa N Borrell; Fred Lurmann; Talat S Islam; Adam Davis; Harold J Farber; Kelley Meade; Pedro C Avila; Denise Serebrisky; Kirsten Bibbins-Domingo; Michael A Lenoir; Jean G Ford; Emerita Brigino-Buenaventura; William Rodriguez-Cintron; Shannon M Thyne; Saunak Sen; Jose R Rodriguez-Santana; Carlos D Bustamante; L Keoki Williams; Frank D Gilliland; W James Gauderman; Rajesh Kumar; Dara G Torgerson; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2014-10-06       Impact factor: 10.793

View more
  6 in total

1.  Residential secondhand smoke in a densely populated urban setting: a qualitative exploration of psychosocial impacts, views and experiences.

Authors:  Grace Ping Ping Tan; Odelia Teo; Yvette van der Eijk
Journal:  BMC Public Health       Date:  2022-06-11       Impact factor: 4.135

2.  Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis.

Authors:  Hua Yan; Guiying Qian; Rui Yang; Zichen Luo; Xianzheng Wang; Tong Xie; Xia Zhao; Jinjun Shan
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

3.  Assessment of Respiratory Health Symptoms and Asthma in Children near a Drying Saline Lake.

Authors:  Shohreh F Farzan; Mitiasoa Razafy; Sandrah P Eckel; Luis Olmedo; Esther Bejarano; Jill E Johnston
Journal:  Int J Environ Res Public Health       Date:  2019-10-11       Impact factor: 3.390

4.  Exhaled Nitric Oxide in Wheezy Infants Predicts Persistent Atopic Asthma and Exacerbations at School Age.

Authors:  Maria P White; Tessa K Kolstad; Molly Elliott; Elizabeth S Cochrane; David C Stamey; Jason S Debley
Journal:  J Asthma Allergy       Date:  2020-01-07

5.  The burden of asthma in an inner-city area: A historical review 10 years after Isaac.

Authors:  Blanca Estela Del-Rio-Navarro; Elsy Maureen Navarrete-Rodríguez; Arturo Berber; Nayely Reyes-Noriega; Luis García-Marcos Álvarez
Journal:  World Allergy Organ J       Date:  2020-01-08       Impact factor: 4.084

Review 6.  Cigarette Smoke Exposure, Pediatric Lung Disease, and COVID-19.

Authors:  Marta Schiliro; Elizabeth R Vogel; Lucia Paolini; Christina M Pabelick
Journal:  Front Physiol       Date:  2021-04-27       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.